Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $121.9M |
| Sales growthchange from the year before | -0.1% |
| Net marginshare of sales kept as profit | 168.9% |
| Free-cash-flow marginspare cash generated per $100 of sales | 151.1% |
| Return on equityprofit vs. shareholders' accounting value | 11.1% |
| Debt / equitydebt vs. shareholders' accounting value | 0.30 |
| Change in share countnegative = the company is buying back its shares | +0.6% |
1 insider sold $359K on the open market.
| Abbruzzese Marco AVice Chair | SoldAug 4 | 2,441 shat $81.59 · $199K |
| Abbruzzese Marco AVice Chair | SoldAug 3 | 2,000 shat $79.84 · $160K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy